Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07468188 · ClinicalTrials.gov registry record · NA

Diabetes Body Project 2

A NA study of Type 2 Diabetes and Eating Disorders, sponsored by Joslin Diabetes Center.

Recruiting
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT07468188 is a NA study of Type 2 Diabetes and Eating Disorders that is actively recruiting participants, run by Joslin Diabetes Center. The registered enrollment target is 42 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07468188, a NA study of Type 2 Diabetes and Eating Disorders, is actively recruiting participants, sponsored by Joslin Diabetes Center.

RECRUITING
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 diabetes (T2D) called the Diabetes Body Project 2 (DBP2). The Diabetes Body Project 2 (DBP2) will be adapted from the Diabetes Body Project, which is an eating disorder prevention program developed to improve satisfaction with body image and diabetes management for young women with type 1 diabetes (DBP). The study is looking to see if the DBP is effective in improving body image concerns, reducing disordered eating behaviors and improving glycemic control in women with T2D.

Interventions

  • BEHAVIORAL Body Project Type 2

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2025-01-24
Est. Completion 2027-05-31
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT07468188

The ClinicalTrials.gov registry entry for NCT07468188 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Body Project Type 2 is the first listed.

NCT07468188 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07468188 about?

NCT07468188 is a clinical study titled "Diabetes Body Project 2". The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 diabetes (T2D) called the Diabetes Body Project 2 (DBP2). The Diabetes Body Project 2 (DBP2) will be adapted from the Diabetes Body Project, wh...

What is the current status of trial NCT07468188?

This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2025-01-24. Estimated completion is 2027-05-31.

What conditions does trial NCT07468188 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Eating Disorders.

What interventions are being tested in trial NCT07468188?

The interventions under investigation include: Body Project Type 2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT07468188?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07468188 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.